Mg0007 50323 — Honolulu, Hawaii

Mg0007 50323 is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mg0007 50323 has participated in 1 clinical trials.

Therapeutic areas: Generalized Myasthenia Gravis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mg0007 50323?

Mg0007 50323 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mg0007 50323 conducted?

Mg0007 50323 has 1 clinical trials on record. Their work covers Generalized Myasthenia Gravis.

Is Mg0007 50323 accredited by Crixeo Health?

Mg0007 50323 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mg0007 50323?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.